Windlas Biotech Ltd Company History

Commenced operations at Dehradun Plant – I situated at 40/1, Mohabewala Industrial Area, Dehradun 248 110 and initiated commercial production

Commenced operations at Dehradun Plant – IV situated at plot no. 183 and 192, Mohabewala Industrial Area, Dehradun 248 110

Revenues crossed Rs. 1,000 million for the FY 2009-10

Received first USFDA inspection clearance for the WHC Plant

Revenues crossed Rs. 2,000 million for the FY 2013-14

Commenced operations at Dehradun Plant – II situated at khasra no. 141 to 143 and 145, Mohabewala Industrial Area, Dehradun 248 110

Investment of Rs. 750 million from Tano India Private Equity Fund II

Revenues crossed Rs. 3,000 million for the FY 2016-17

Launched first product in the United States from the Dehradun Plant – IV situated at plot no. 183 and 192, Mohabewala Industrial Area, Dehradun 248 110

Commenced operations at Dehradun Plant – III situated at plot no. 39, Pharmacity, Selaqui, Dehradun 248 197

Approval of Scheme of Amalgamation of the erstwhile subsidiary, Windlas Healthcare, with and into the Company